Finance

Lists
OKYO:NASDAQ
OKYO Pharma Ltd
1,42 $
-0,88%
(-0,013) 1D
14 հոկ, 11:52:27 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
1,45 $
High
1,45 $
Low
1,38 $
Mkt. cap
74,66 մլն
Avg. vol.
72,69 հզր
Volume
14,95 հզր
52-wk high
3,20 $
52-wk low
1,26 $
EPS
-0,32 $
Beta
-0,03
Shares outstanding
52,48 մլն
No. of employees
5
Open
1,45 $
High
1,45 $
Low
1,38 $
Mkt. cap
74,66 մլն
Avg. vol.
72,69 հզր
Volume
14,95 հզր
52-wk high
3,20 $
52-wk low
1,26 $
EPS
-0,32 $
Beta
-0,03
Shares outstanding
52,48 մլն
No. of employees
5
News stories
From web sources and news partners
About OKYO Pharma Ltd
CEO-
Employees5
Founded2007
HeadquartersԼոնդոն, Անգլիա, Միացյալ Թագավորություն
Sector-
Websiteokyopharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to OKYO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OKYO in the last 3 months.
Highest
Current 1,42 $
7,00 $ (+391,23%)
Average
6,00 $ (+321,05%)
Lowest
5,00 $ (+250,88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
5,00 $
+250,9%
10/06/2026
Biren Amin
Piper Sandler
Buy
Maintained
7,00 $
+391,2%
08/27/2026
William Wood
B. Riley Securities
Buy
Initiated
5,00 $
+250,9%
12/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
-
-
-
-
Cost of goods sold
1,27 մլն
1,27 մլն
2,07 մլն
2,07 մլն
Cost of revenue
1,27 մլն
1,27 մլն
2,07 մլն
2,07 մլն
Research and development expenses
-22,02 հզր
-22,02 հզր
926,55 հզր
926,55 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-22,02 հզր
-22,02 հզր
926,55 հզր
926,55 հզր
Total operating expenses
1,25 մլն
1,25 մլն
3,00 մլն
3,00 մլն
Operating income
-1,25 մլն
-1,25 մլն
-3,00 մլն
-3,00 մլն
Other non operating income
-
-
-140,00
-140,00
EBT including unusual items
-1,29 մլն
-1,29 մլն
-3,18 մլն
-3,18 մլն
EBT excluding unusual items
-1,29 մլն
-1,29 մլն
-3,18 մլն
-3,18 մլն
Income tax expense
26,00
26,00
3,97 հզր
3,97 հզր
Effective tax rate
-
-
-0,12%
-0,12%
Other operating expenses
-
-
-
-
Net income
-1,29 մլն
-1,29 մլն
-3,18 մլն
-3,18 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
16,05 հզր
16,05 հզր
Interest expense
-42,29 հզր
-42,29 հզր
-194,68 հզր
-194,68 հզր
Net interest expenses
-42,29 հզր
-42,29 հզր
-178,63 հզր
-178,63 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,25 մլն
-1,25 մլն
-3,00 մլն
-3,00 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps